Next Generation Sequencers - Global Strategic Business Report

The global market for Next Generation Sequencers is estimated at US$14.1 Billion in 2023 and is projected to reach US$43.3 Billion by 2030, growing at a CAGR of 17.4% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The broad application of NGS across various sectors underscores its advantages of high throughput, speed, and cost-efficiency. In clinical research, NGS aids in identifying genetic variations associated with diseases, paving the way for targeted therapies and playing a vital role in reproductive health through genetic anomaly screenings. In agriculture, it accelerates crop improvement by facilitating plant genetic studies, leading to the cultivation of more robust crop varieties. NGS has been particularly crucial during global health emergencies, such as the COVID-19 pandemic, by enabling rapid viral genomic sequencing, which assists in tracking mutations and vaccine development. The future of NGS looks promising with ongoing advancements expected to enhance personalized medicine, agricultural development, and more, fueled by growth drivers such as integration with cloud computing, advancements in bioinformatics, rising consumer interest in personalized medicine, expanding academic and clinical research, evolving regulatory and ethical frameworks, strategic collaborations, and increased investments in emerging markets.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Next Generation Sequencers Consumables segment, which is expected to reach US$26.6 Billion by 2030 with a CAGR of a 17.2%. The Next Generation Sequencers Platforms segment is also set to grow at 16.3% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $3.8 Billion in 2023, and China, forecasted to grow at an impressive 22.9% CAGR to reach $10.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Next Generation Sequencers Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Next Generation Sequencers Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Next Generation Sequencers Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Becton, Dickinson and Company, Fluidigm Corporation, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 93 Featured):

• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Fluidigm Corporation
• Illumina Inc.
• Oxford Gene Technology
• Oxford Nanopore Technologies
• Pacific Biosciences of California Inc.
• QIAGEN N.V.
• RainDance Technologies Inc.
• Roche Sequencing
• Thermo Fischer Scientific Inc.